BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the sale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback